Search results for "Mesenchymal Stem Cell"

showing 10 items of 399 documents

MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation

2019

Mesenchymal stromal cells (hMSCs) display a pleiotropic function in bone regeneration. The signaling involved in osteoblast commitment is still not completely understood, and that determines the failure of current therapies being used. In our recent studies, we identified two miRNAs as regulators of hMSCs osteoblast differentiation driving hypoxia signaling and cytoskeletal reorganization. Other signalings involved in this process are epithelial to mesenchymal transition (EMT) and epidermal growth factor receptor (EGFR) signalings through the regulation of Yes-associated protein (YAP)/PDZ-binding motif (TAZ) expression. In the current study, we investigated the role of miR-33a family as a (…

epithelial mesenchymal transitionregenerative medicinePDZ DomainsCell CommunicationArticlemicroRNAmedicineHumansEpidermal growth factor receptorEpithelial–mesenchymal transitionBone regenerationCells CulturedEGFR inhibitorsAdaptor Proteins Signal TransducingOsteoblastsmicroRNAbiologyMesenchymal stem cellComputational BiologyOsteoblastMesenchymal Stem CellsYAP-Signaling ProteinsGeneral MedicinePhenotypeCell biologymicroRNAsErbB Receptorsmedicine.anatomical_structureTranscriptional Coactivator with PDZ-Binding Motif Proteinsmesenchymal stromal cellbiology.proteinTrans-Activatorsmesenchymal stromal cellsEGFR signalingSignal TransductionTranscription FactorsCells
researchProduct

Gene expression in TGFbeta-induced epithelial cell differentiation in a three-dimensional intestinal epithelial cell differentiation model

2006

Abstract Background The TGFβ1-induced signal transduction processes involved in growth and differentiation are only partly known. The three-dimensional epithelial differentiation model, in which T84 epithelial cells are induced to differentiate either with TGFβ1 or IMR-90 mesenchymal cell-secreted soluble factors, is previously shown to model epithelial cell differentiation seen in intestine. That model has not been used for large scale gene expression studies, such as microarray method. Therefore the gene expression changes were studied in undifferentiated and differentiated three-dimensional T84 cultures with cDNA microarray method in order to study the molecular changes and find new play…

geenien ilmeneminenlcsh:QH426-470ColonCellular differentiationlcsh:BiotechnologyCell Culture TechniquesBiologyMesodermTransforming Growth Factor beta103 medical and health sciences0302 clinical medicineLääketieteen bioteknologia - Medical biotechnologyCell Line Tumorlcsh:TP248.13-248.65Gene expressionGeneticsHumansIntestinal epithelial cell differentiationTGF-betageeniekspressioIntestinal MucosaOligonucleotide Array Sequence Analysis030304 developmental biologyEpithelial cell differentiationRegulation of gene expression0303 health sciencesTGB-betaepithelial cellMesenchymal stem cellCell DifferentiationEpithelial CellsdifferentiationFibroblastsepiteelisoluMolecular biologyCell biologylcsh:GeneticsGene Expression RegulationerilaistuminenCell culture030220 oncology & carcinogenesisSignal transductionmicroarraygeenilastuSignal TransductionResearch ArticleBiotechnology
researchProduct

Wharton’s jelly mesenchymal stem cells differentiation into hepatocyte-like cells: functional characterization and expression of immunomodulatory mol…

2015

Mesenchymal stem cells derived from Wharton’s jelly (WJ-MSCs) recently emerged as promising tools for cellular therapy due to their ability to differentiate into diverse cell types and their immunomodulatory features. Little is known on the expression of immunomodulatory molecules in mature cells differentiated from WJ-MSCs, therefore we aimed to characterize the extent of maintenance of the naive traits of these cells also in a highly specialized differentiated counterpart. WJ-MSCs were differentiated into hepatocyte-like cells (HLCs) with a four weeks protocol. RT-PCR, flow cytometry, IHC and ICC were performed to assess expression of key markers in both undifferentiated and differentiate…

hepatocyte differentiationmesenchymal stem cellsimmune modulationUmbilical cord; perinatal stem cells; mesenchymal stem cells; hepatocyte differentiation; immune modulation.Settore BIO/16 - Anatomia UmanaWharton's jellyperinatal stem cellcell therapyUmbilical cordliver
researchProduct

At the roots of tolerogenicity and immune modulation: an in vitro and in situ survey on the expression of immunomodulatory molecules by Wharton’s jel…

2012

immune modulationSettore BIO/16 - Anatomia Umanatolerogenicityimmunomodulatory moleculeWharton’s jelly mesenchymal stem cells
researchProduct

Characterization of Rabbit Mesenchymal Cell Attachment on Calcium Phosphate Surface

2014

In the current study, the effect of three different treated surfaces of hydroxyapatite and β-tricalcium phosphate on mesenchymal cell attachment has been investigated. Calcium phosphate powders have been synthesized, uniaxially pressed, polished and sintered. Mesenchymal cells have been seeded onto unpolished, polished and polished-thermally etched ceramic samples. The ceramic samples have been characterized by XRD, FTIR and SEM. Results have shown that the best cell attachment and morphology are on the unpolished surface indicating that relatively rough surface is better for cell application.

implant surfaceMaterials scienceMorphology (linguistics)mesenchymal cellsMesenchymal stem celltechnology industry and agriculturechemistry.chemical_elementRabbit (nuclear engineering)CalciumPhosphateβ-tricalcium phosphatehumanitieseye diseasesHydroxyapatitechemistry.chemical_compoundchemistryChemical engineeringvisual_artRough surfaceHydroxyapatite implant surface mesenchymal cells β-tricalcium phosphatevisual_art.visual_art_mediumCeramicFourier transform infrared spectroscopyBiomedical engineering
researchProduct

Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages

2019

Fibroblasts play an important role as members of the innate immune system through the secretion of COX-2-derived inflammatory mediators such as prostaglandin E-2 (PGE(2)). However, it has been described that dermal fibroblasts behave like mesenchymal stem cells reducing lymphocyte recruitment and dendritic cell activation through PGE(2) release. As the role of fibroblasts in psoriasis remains poorly characterized, in the present study we have evaluated the possible influence of PGE(2) derived from dermal fibroblasts as modulator of the immune response in psoriatic skin. Our results indicate that under inflammatory conditions, psoriatic fibroblasts showed defective induction of COX-2, which …

lcsh:Immunologic diseases. AllergyAdultMale0301 basic medicineTHP-1 CellsLymphocyteImmunologyInflammationDinoprostoneYoung Adult03 medical and health sciences0302 clinical medicineImmune systemPsoriasismedicineHumansImmunology and AllergyPsoriasisProstaglandin E2SkinOriginal ResearchInflammationInnate immune systemChemistryMacrophagesMesenchymal stem cellpsoriasisDendritic cellMiddle AgedFibroblastsmedicine.diseaseCyclooxygenasecyclooxygenase030104 developmental biologymedicine.anatomical_structureCyclooxygenase 2inflammationCancer researchFemalemedicine.symptomlcsh:RC581-607030215 immunologymedicine.drug
researchProduct

Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development

2012

Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since the ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009. The Committee for Advanced Therapies (CAT) has been established at the European Medicines Agency (EMA) for centralized classification, certification and evaluation procedures, and other ATMP-related tasks. Guidance documents, initiatives, and interaction platforms are available to make the new framework more accessible for small- and medium-sized enterprises, academia, hospitals, and foundation…

lcsh:Immunologic diseases. Allergymesenchymal stem/progenitor cellMesenchymal stem cells (MSC)ImmunologyReview ArticleCertificationBest interestsAgency (sociology)Hospital Exemption authorisationImmunology and AllergyMedicinemedia_common.cataloged_instanceProduct (category theory)European unionHospital Exemptionmedia_commonbusiness.industrynational competent authorityCommittee for Advanced TherapiesCell therapy medicinal product (CTMP)AuthorizationGuidance documentsCommittee for Advanced Therapies (CAT)Engineering managementNew product developmentadvanced therapy medicinal productlcsh:RC581-607businesscell therapy medicinal productAdvanced therapy medicinal product (ATMP)Frontiers in Immunology
researchProduct

Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems

2019

The secretion of potential therapeutic factors by mesenchymal stem cells (MSCs) has aroused much interest given the benefits that it can bring in the field of regenerative medicine. Indeed, the in vitro multipotency of these cells and the secretive capacity of both angiogenic and immunomodulatory factors suggest a role in tissue repair and regeneration. However, during culture, MSCs rapidly lose the expression of key transcription factors associated with multipotency and self-renewal, as well as the ability to produce functional paracrine factors. In our study, we show that a three-dimensional (3D) culture method is effective to induce MSC spheroid formation, to maintain the multipotency an…

lcsh:Internal medicineAmnionArticle SubjectRegeneration (biology)Mesenchymal stem cellCell BiologyBiologyRegenerative medicineMicrovesiclesIn vitroCell biologyParacrine signallingmedicine.anatomical_structurehuman amnion-derived mesenchymal stem cellmedicinelcsh:RC31-1245Molecular BiologyTranscription factorResearch Article
researchProduct

Pericytes: a target for in vivo reprogramming?

2013

medicine.anatomical_structureNeurologyIn vivoMesenchymal stem cellNeurogenesismedicineNeurology (clinical)BiologyBlood–brain barrierReprogrammingCell biologyFuture Neurology
researchProduct

Isolation and characterization of pluripotent cells from the subendocardial layer of human hearts from chronic heart failure patients

2008

medicine.medical_specialtyIsolation (health care)business.industryHeart failureInternal medicineMesenchymal stem cellCardiologymedicineSubendocardial LayerCardiology and Cardiovascular Medicinebusinessmedicine.diseaseRegenerative medicineEuropean Journal of Heart Failure Supplements
researchProduct